June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Optical coherence tomography characteristics of Intraretinal hyperreflective foci associated with diabetic retinopathy and age-related macular degeneration
Author Affiliations & Notes
  • maryam ashrafkhorasani
    Doheny Eye Institute, Pasadena, California, United States
    University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States
  • abbas habibi
    Doheny Eye Institute, Pasadena, California, United States
    University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States
  • Mehdi Emamverdi
    Doheny Eye Institute, Pasadena, California, United States
    University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States
  • Muneeswar Gupta Nittala
    Doheny Eye Institute, Pasadena, California, United States
  • Swetha B Velaga
    Doheny Eye Institute, Pasadena, California, United States
  • Charles Clifton Wykoff
    Retina Consultants of Texas, Houston, Texas, United States
    Blanton eye institute, Houston, Texas, United States
  • SriniVas R Sadda
    Doheny Eye Institute, Pasadena, California, United States
    University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States
  • Footnotes
    Commercial Relationships   maryam ashrafkhorasani None; abbas habibi None; Mehdi Emamverdi None; Muneeswar Gupta Nittala None; Swetha B Velaga None; Charles Wykoff 4DMT, AbbVie, Adverum, Aerie, AGTC, Alcon, Alimera, Allergan, Allgenesis, Alnylam, Annexon, Apellis, Arrowhead, Bausch + Lomb, Bayer, Bionic Vision, Boehringer Ingelheim, Chengdu Kanghong, Cholgene, Clearside, Curacle, EyePoint, Foresite, Frontera, Genentech, Gyroscope, IACTA, IVERIC Bio, Janssen, Kato, Kiora, Kodiak, Kriya, Merck, Nanoscope, NGM, Notal Vision, Novartis, OccuRx, Ocular Therapeutix, Ocuterra, OliX, ONL, Opthea, Palatin, PerceiveBio, Perfuse, PolyPhotonix, Ray, RecensMedical, Regeneron, RegenXBio, Resonance, Roche, SciNeuro, Stealth, Surrozen, THEA, TissueGen, Valo, Verana, Vitranu, Code C (Consultant/Contractor), 4DMT, Adverum, Aerie, AffaMed, Aldeyra, Alexion, Alimera, Alkahest, Allergan, Allgenesis, Amgen, Annexin, Annexon, Apellis, Asclepix, Bayer, Boehringer Ingelheim, Chengdu Kanghong, Clearside, Curacle, EyePoint, Gemini, Genentech, Graybug Vision, Gyroscope, IONIS, iRENIX, IVERIC bio, Kodiak, LMRI, Nanoscope, Neurotech, NGM, Novartis, Ocular Therapeutix, Ocuphire, OcuTerra, Opthea, Oxurion, Oxular, Oyster Point, Perceive Biotherapeutics, RecensMedical, Regeneron, RegenXBio, Roche, SamChunDang Pharm, Sandoz, Taiwan Liposome Company, UNITY, Verily, Xbrane, Code C (Consultant/Contractor), ONL, PolyPhotonix, RecensMedical, TissueGen, Visgenx, Vitranu, Code C (Consultant/Contractor); SriniVas Sadda 4DMT, Abbvie/Allergan, Amgen, Apellis, Astellas, Bayer, Biogen, Boerhinger Ingelheim, Centervue, Genentech/Roche, Heidelberg Engineering, Iveric, Nanoscope, Novartis, Optos, Oxurion, Regeneron, Code C (Consultant/Contractor), Carl Zeiss Meditec, Code F (Financial Support), Nidek, Code R (Recipient), Centervue, Heidelberg Engineering, Nidek, Optos, Topcon, Code S (non-remunerative)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 2133. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      maryam ashrafkhorasani, abbas habibi, Mehdi Emamverdi, Muneeswar Gupta Nittala, Swetha B Velaga, Charles Clifton Wykoff, SriniVas R Sadda; Optical coherence tomography characteristics of Intraretinal hyperreflective foci associated with diabetic retinopathy and age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2023;64(8):2133.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Intraretinal hyperreflective foci (IHRF) are important biomarkers on optical coherence tomography (OCT) in diabetic retinopathy (DR) and age-related macular degeneration (AMD). The etiology of IHRF is presumed to differ between DR and AMD eyes, but their exact origins remain controversial. The study objective was to compare IHRF in eyes with DR vs AMD quantitatively.

Methods : A retrospective analysis was performed on 54 treatment-naive eyes (27 DR and 27 AMD). 9 macular B-scans (Spectralis OCT; 6x6 mm; ART=9; separated by 666 microns) were evaluated in all cases. IHRF was defined as features within the neurosensory retinal layers of ≥ 3 pixels in size and reflectivity similar to or greater than that of the retinal pigment epithelium (RPE) band. IHRF was semi-automatically segmented using Image J (Figure 1). Mean reflectivity (MR), maximum diameter, circularity index (Cir), area, and the angle between the greatest linear dimension (GLD) and the horizontal were computed for each lesion. The MR was normalized using the vitreous and retinal nerve fiber layer (RNFL) reflectivities as dark and bright reference standards, respectively. The presence or absence of a posterior shadow and the axial location were also assessed. Two groups were compared using independent t-tests and chi-square tests.

Results : A total of 1149 IHRF (1051 in DR and 98 in the AMD group) were identified, with a mean of 38.92±35.53 lesions in DR eyes compared to 3.62±3.83 in AMD eyes. Table 1 shows the characteristics of each cohort and IHRF lesions. The mean area of lesions was greater in DR eyes but AMD lesions had higher reflectivity. In AMD eyes, the angle of GLD was greater, suggesting that IHRF was more horizontally elongated. 89% of AMD IHRF were located below the inner border of the outer nuclear layer, compared to 56% of DR eyes (P<0.001). In AMD eyes, 59% of IHRF had posterior shadows compared to 68% in DR eyes.

Conclusions : DR and AMD IHRF display significant differences, with DR lesions typically larger and less reflective than AMD lesions. The prognostic importance of these characteristics of IHRF requires further study.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

Figure 1. Intraretinal hyper-reflective foci (IHRF) on OCT B-scans from eyes with DR (A1, A2) and AMD (B1, B2), with segmented IHRF highlighted in the lower panels (red; A2, B2)

Figure 1. Intraretinal hyper-reflective foci (IHRF) on OCT B-scans from eyes with DR (A1, A2) and AMD (B1, B2), with segmented IHRF highlighted in the lower panels (red; A2, B2)

 

Table 1. IHRF characteristics of eyes with DR and AMD

Table 1. IHRF characteristics of eyes with DR and AMD

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×